Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population-based registry study.

ABSTRACT:

Background and purpose

Health care resource utilization (HCRU) and the economic burden of myasthenia gravis (MG) are significant, but existing studies rarely include comprehensive nationwide data. We examined HCRU and direct and indirect costs associated with MG overall and by disease severity in Denmark, Finland, and Sweden.

Methods

Data were collected retrospectively from nationwide health and social care registries. All individuals ≥18 years of age with ≥2 International Classification of Diseases diagnoses of MG between 2000 and 2020 were included. HCRU, direct (inpatient and outpatient contacts, medication) and indirect costs (early retirement, sick leave, death), and associated factors were calculated.

Results

The full study cohort comprised 8622 people with MG (

SUBMITTER: Piehl F 

PROVIDER: S-EPMC11555013 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature